Amgen to Acquire Five Prime Therapeutics for $1.9 Billion in Cash
Acquisition Includes Bemarituzumab, A Phase 3 Ready, First-In-Class Program For Gastric Cancer, the Third Leading…
Acquisition Includes Bemarituzumab, A Phase 3 Ready, First-In-Class Program For Gastric Cancer, the Third Leading…
ROCKVILLE, Md.--(BUSINESS WIRE)--GlycoMimetics (Nasdaq: GLYC) today announced that Apollomics has dosed the first patient in…
World-class manufacturing base will enhance Asia Pacific customers’ local access to innovative material science solutions…
Wipro to be one of the largest providers of integrated, end-to-end consulting, digital, cloud and…
Series C Co-led by Andreessen Horowitz and General Catalyst, with IVP; Sriram Krishnan from Andreessen…
Australian firm takes the lead in genetics and AI-based technology for personalized medical cannabis treatments…
PITTSBURGH & CHENNAI, India--(BUSINESS WIRE)--Evoqua Water Technologies, an industry leader in mission-critical water treatment solutions,…
Guangzhou IFC sees rapid recovery in 2H2020 and revenue up 31% compared to 1H2020?Yuexiu REIT's…
The new web security service enables WebNIC partners to revolutionize their SSL business by participating…
The XinFin community has decided to reduce the supply of XDCE tokens, after the last…